Foundayo (orforglipron) is another oral GLP-1 option, flexible in timing and without food restrictions
Unfortunately, it is not possible to look at someone with the naked eye and determine if they have uterine fibroids
External resources FDA: Clarifies policies for compounders as GLP-1 supply stabilizes Pharmacy Times: Navigating FDA compounding regulations for tirzepatide In case I do not see you, good afternoon, good evening, and good night
doi: 10.3390/molecules25204866
Weight loss trajectory may be affected when both medications are used together, as their combined appetite-suppressant effects could lead to more rapid weight reduction than with Wegovy alone
Dehydrated states impair lipolysis efficiency, potentially reducing the effectiveness of both compounds